Pain on injection of methohexitone. The use of lignocaine to modify pain on injection of methohexitone during anaesthesia for electroconvulsive therapy.
The present study was designed to assess the incidence of pain when methohexitone was administered to 35 depressed patients who had electroconvulsive therapy, and to determine whether the use of lignocaine could modify this, without affecting seizure duration. The same patients were studied during three separate treatment sessions; they received either methohexitone alone or mixed with, or preceded by, lignocaine 10 mg. Six (17%) patients spontaneously complained of pain during injection of methohexitone alone; the use of lignocaine prior to methohexitone reduced this to zero (p less than 0.05). A total of 49% patients reported pain during injection of methohexitone; the use of lignocaine either mixed with, or given prior to, methohexitone significantly reduced this to 23% and 20% respectively (p less than 0.05). Seizure duration was not significantly different during the three treatments.
Simpson
K H
KH
University Department of Anaesthesia, St James's University Hospital, Leeds.
Halsall
P J
PJ
Sides
C A
CA
Keeler
J F
JF
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000771:Anesthesia, Intravenous / Q000009:adverse effects*; D004338:Drug Combinations; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage; D008297:Male; D008723:Methohexital / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced* / Q000517:prevention & control
D004338:Drug Combinations; D008012:Lidocaine; D008723:Methohexital